Seipin is required for converting nascent to mature lipid droplets

  1. Huajin Wang
  2. Michel Becuwe
  3. Benjamin E Housden
  4. Chandramohan Chitraju
  5. Ashley J Porras
  6. Morven M Graham
  7. Xinran N Liu
  8. Abdou Rachid Thiam
  9. David B Savage
  10. Anil K Agarwal
  11. Abhimanyu Garg
  12. Maria-Jesus Olarte
  13. Qingqing Lin
  14. Florian Fröhlich
  15. Hans Kristian Hannibal-Bach
  16. Srigokul Upadhyayula
  17. Norbert Perrimon
  18. Tomas Kirchhausen
  19. Christer S Ejsing
  20. Tobias C Walther  Is a corresponding author
  21. Robert V Farese  Is a corresponding author
  1. Carnegie Mellon University, United States
  2. Harvard T. H. Chan School of Public Health, United States
  3. Harvard Medical School, United States
  4. Yale School of Medicine, United States
  5. PSL Research University, France
  6. The University of Cambridge Metabolic Research Laboratories, United Kingdom
  7. UT Southwestern Medical Center, United States
  8. University of Southern Denmark, Denmark

Abstract

How proteins control the biogenesis of cellular lipid droplets (LDs) is poorly understood. Using Drosophila and human cells, we show here that seipin, an ER protein implicated in LD biology, mediates a discrete step in LD formation-the conversion of small, nascent LDs to larger, mature LDs. Seipin forms discrete and dynamic foci in the ER that interact with nascent LDs to enable their growth. In the absence of seipin, numerous small, nascent LDs accumulate near the ER and most often fail to grow. Those that do grow prematurely acquire lipid synthesis enzymes and undergo expansion, eventually leading to the giant LDs characteristic of seipin deficiency. Our studies identify a discrete step of LD formation, namely the conversion of nascent LDs to mature LDs, and define a molecular role for seipin in this process, most likely by acting at ER-LD contact sites to enable lipid transfer to nascent LDs.

Article and author information

Author details

  1. Huajin Wang

    Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Michel Becuwe

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Benjamin E Housden

    Department of Genetics, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Chandramohan Chitraju

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Ashley J Porras

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Morven M Graham

    Department of Cell Biology, Yale School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Xinran N Liu

    Department of Cell Biology, Yale School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Abdou Rachid Thiam

    Laboratoire de Physique Statistique, École Normale Supérieure, PSL Research University, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  9. David B Savage

    Wellcome Trust-MRC Institute of Metabolic Science, The University of Cambridge Metabolic Research Laboratories, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Anil K Agarwal

    Division of Nutrition and Metabolic Diseases, UT Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Abhimanyu Garg

    Division of Nutrition and Metabolic Diseases, UT Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Maria-Jesus Olarte

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Qingqing Lin

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Florian Fröhlich

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Hans Kristian Hannibal-Bach

    Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  16. Srigokul Upadhyayula

    Departments of Cell Biology and Pediatrics, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Norbert Perrimon

    Department of Genetics, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Tomas Kirchhausen

    Departments of Cell Biology and Pediatrics, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  19. Christer S Ejsing

    Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  20. Tobias C Walther

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    For correspondence
    twalther@hsph.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
  21. Robert V Farese

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    For correspondence
    robert@hsph.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8103-2239

Funding

National Institutes of Health (GM099844, GM097194, GM-075252)

  • Tomas Kirchhausen
  • Tobias C Walther
  • Robert V Farese

Howard Hughes Medical Institute

  • Norbert Perrimon
  • Tobias C Walther

G Harold and Leila Y. Mathers Foundation

  • Tobias C Walther

Villum Fonden (VKR023439)

  • Christer S Ejsing

Danish Council for Strategic Research (11-116196)

  • Christer S Ejsing

Wellcome Trust (WT107064)

  • David B Savage

Cambridge NIHR BRC

  • David B Savage

Biogen

  • Tomas Kirchhausen

Canadian Institutes of Health Research (Fellowship Award)

  • Huajin Wang

European Molecular Biology Organization (Longterm Fellowship EMBOLFT355)

  • Michel Becuwe

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2016, Wang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 8,838
    views
  • 2,151
    downloads
  • 323
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Huajin Wang
  2. Michel Becuwe
  3. Benjamin E Housden
  4. Chandramohan Chitraju
  5. Ashley J Porras
  6. Morven M Graham
  7. Xinran N Liu
  8. Abdou Rachid Thiam
  9. David B Savage
  10. Anil K Agarwal
  11. Abhimanyu Garg
  12. Maria-Jesus Olarte
  13. Qingqing Lin
  14. Florian Fröhlich
  15. Hans Kristian Hannibal-Bach
  16. Srigokul Upadhyayula
  17. Norbert Perrimon
  18. Tomas Kirchhausen
  19. Christer S Ejsing
  20. Tobias C Walther
  21. Robert V Farese
(2016)
Seipin is required for converting nascent to mature lipid droplets
eLife 5:e16582.
https://doi.org/10.7554/eLife.16582

Share this article

https://doi.org/10.7554/eLife.16582

Further reading

    1. Cell Biology
    Kaima Tsukada, Rikiya Imamura ... Mikio Shimada
    Research Article

    Polynucleotide kinase phosphatase (PNKP) has enzymatic activities as 3′-phosphatase and 5′-kinase of DNA ends to promote DNA ligation and repair. Here, we show that cyclin-dependent kinases (CDKs) regulate the phosphorylation of threonine 118 (T118) in PNKP. This phosphorylation allows recruitment to the gapped DNA structure found in single-strand DNA (ssDNA) nicks and/or gaps between Okazaki fragments (OFs) during DNA replication. T118A (alanine)-substituted PNKP-expressing cells exhibited an accumulation of ssDNA gaps in S phase and accelerated replication fork progression. Furthermore, PNKP is involved in poly (ADP-ribose) polymerase 1 (PARP1)-dependent replication gap filling as part of a backup pathway in the absence of OFs ligation. Altogether, our data suggest that CDK-mediated PNKP phosphorylation at T118 is important for its recruitment to ssDNA gaps to proceed with OFs ligation and its backup repairs via the gap-filling pathway to maintain genome stability.

    1. Cell Biology
    2. Neuroscience
    Vibhavari Aysha Bansal, Jia Min Tan ... Toh Hean Ch'ng
    Research Article

    The emergence of Aβ pathology is one of the hallmarks of Alzheimer’s disease (AD), but the mechanisms and impact of Aβ in progression of the disease is unclear. The nuclear pore complex (NPC) is a multi-protein assembly in mammalian cells that regulates movement of macromolecules across the nuclear envelope; its function is shown to undergo age-dependent decline during normal aging and is also impaired in multiple neurodegenerative disorders. Yet not much is known about the impact of Aβ on NPC function in neurons. Here, we examined NPC and nucleoporin (NUP) distribution and nucleocytoplasmic transport using a mouse model of AD (AppNL-G-F/NL-G-F) that expresses Aβ in young animals. Our studies revealed that a time-dependent accumulation of intracellular Aβ corresponded with a reduction of NPCs and NUPs in the nuclear envelope which resulted in the degradation of the permeability barrier and inefficient segregation of nucleocytoplasmic proteins, and active transport. As a result of the NPC dysfunction App KI neurons become more vulnerable to inflammation-induced necroptosis – a programmed cell death pathway where the core components are activated via phosphorylation through nucleocytoplasmic shutting. Collectively, our data implicates Aβ in progressive impairment of nuclear pore function and further confirms that the protein complex is vulnerable to disruption in various neurodegenerative diseases and is a potential therapeutic target.